Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Some Diseases Can Be Prevented Only by Vaccines: Dr Sonobe
July 19, 2010
- MCI to Provide Contents of Online Version of NEJM
July 19, 2010
- Alliances to Be Accelerated in Drug Discovery: Dr Nishikawa of NBI
July 19, 2010
- Oxiconazole-Based OTC Drugs Approved for Vaginal Candida
July 19, 2010
- Health & Welfare Cooperative Union to Consider Joint Purchase of Drugs
July 19, 2010
- SymBio Enters PII for Bendamustine for Multiple Myeloma
July 19, 2010
- Victoza to Drive Sales of Novo Nordisk to ¥100.0 Bil.
July 19, 2010
- JMA Concerned about Promotional Use of Medical DB by Drug Firms
July 19, 2010
- Banyu to Recruit Subjects in More Prefectures for PII Trial of MK-8669
July 19, 2010
- OHARA Pharm. Licenses Erwinase from EUSA Pharma
July 19, 2010
- NEW PRODUCTS
July 19, 2010
- Torii to Enter PIII for Sublingual Desensitization Therapy for Pollinosis
July 19, 2010
- Shionogi, Galderma Boost Acne Patients Educational Campaign
July 19, 2010
- Multiple Companies to Launch Generics of Pariet
July 19, 2010
- GW, Otsuka to Extend Cannabinoid Research Collaboration for 3 Years
July 19, 2010
- Banyu Invite 200 Employees to Early Retirement Program
July 19, 2010
- Nichi-Iko to Promote Generic of Amaryl with sanofi-aventis' Support
July 19, 2010
- Linagliptin Effective for Controlling Blood Glucose both in Mono-, Combination Therapy
July 19, 2010
- Maruishi Aims at Sales of ¥50.0 Bil. in Mid Term
July 19, 2010
- Teva-Kowa Aims at Sales of ¥20.0 Bil. in 2010
July 19, 2010
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…